Nano-X Imaging (NNOX) EBT Margin (2022 - 2026)
Nano-X Imaging (NNOX) posted quarterly EBT Margin of 329.13% for Q1 2026, up 14422.0% year-on-year from N/an in Q1 2025, and up 65.09% on a QoQ basis from 942.91% in Q4 2025.
Nano-X Imaging (NNOX) EBT Margin (2022 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported EBT Margin for 5 consecutive years, with 329.13% the latest figure, recorded in Q1 2026.
- Quarterly EBT Margin rose 14422.0% year-over-year to 329.13% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 535.06% (down 5984.0% YoY) and the FY2025 annual result came in at 345.13%, down 21583.0% from the prior year.
- EBT Margin rose to 329.13% in Q1 2026 per NNOX's latest filing, from 942.91% in the prior quarter.
- Over the last five years, EBT Margin for NNOX reached as high as 329.13% in Q1 2026 and fell as low as 2526.69% in Q4 2022.
- A 5-year average of 736.43% and a median of 484.47% in 2023 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2023 — EBT Margin jumped 209586 bps — and 2025, when it sank 47108 bps.
- Year by year, EBT Margin stood at 2526.69% in 2022, then soared by 83 bps to 430.83% in 2023, then declined by 10 bps to 471.83% in 2024, then tumbled by 100 bps to 942.91% in 2025, then soared by 65 bps to 329.13% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 329.13%, 942.91%, and 399.71% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | -329.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -329.13% |
| Dec 31, 2025 | -942.91% |
| Sep 30, 2025 | -399.71% |
| Jun 30, 2025 | -481.58% |
| Mar 31, 2025 | -473.36% |
| Dec 31, 2024 | -471.83% |
| Sep 30, 2024 | -453.08% |
| Jun 30, 2024 | -505.78% |
| Mar 31, 2024 | -483.16% |
| Dec 31, 2023 | -430.83% |
| Sep 30, 2023 | -866.56% |
| Jun 30, 2023 | -675.87% |
| Mar 31, 2023 | -484.47% |
| Dec 31, 2022 | -2,526.69% |
| Sep 30, 2022 | -800.82% |
| Jun 30, 2022 | -986.91% |
| Mar 31, 2022 | -1,206.64% |